Financing, Equity Capital Markets

Replimune Group, Inc.

12/22
|
$258.8 Million
Replimune
Piper Sandler served as bookrunner for Replimune Group, Inc. on a follow-on offering
Sub-Type
Follow-On Offering
Sub-Sector
Biopharma